Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169806 · ClinicalTrials.gov registry record · NA
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
A NA study of Hyperparathyroidism and Renal Calculi, sponsored by Indiana Kidney Stone Institute.
- Active
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT00169806: Active NA study of Hyperparathyroidism and Renal Calculi, sponsored by Indiana Kidney Stone Institute.
NCT00169806 is a NA study of Hyperparathyroidism and Renal Calculi that is active but no longer recruiting, run by Indiana Kidney Stone Institute. The registered enrollment target is 600 participants, above the 48-participant average among 7 other Hyperparathyroidism trials with a reported enrollment target (1150% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00169806, a NA study of Hyperparathyroidism and Renal Calculi, is active but no longer recruiting, sponsored by Indiana Kidney Stone Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
Kidney stones are very common. They affect 3-5% of the population in the United States. Many people are hospitalized for the treatment of kidney stones and some may die. Better understanding of what causes kidney stones is useful in both the treatment and prevention of kidney stones. However, exactly what causes kidney stones is unknown. The most common type of kidney stones contains calcium, which sometimes is attached to a part of the kidney important in producing the final urine, called the papilla. The investigators have noticed that persons who form kidney stones seem to have more papilla with stones attached. They propose to study these areas of the papilla, called Randall's plaques (named after their discoverer), in patients undergoing surgery for kidney stones.
Conditions Studied
Interventions
- OTHER videotape for mapping of renal anatomy and papillary biopsy
Study Locations (1)
Indiana
- IU Health North Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 1998-11 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT00169806 still lists
NCT00169806 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 48-participant average among 7 other Hyperparathyroidism trials with a reported enrollment target (1150% higher).
The record links to 5 conditions, with Hyperparathyroidism appearing as the primary indexed condition, and to 1 intervention - of which videotape for mapping of renal anatomy and papillary biopsy is the first listed.
NCT00169806 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT00169806 about?
NCT00169806 is a clinical study titled "Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis". Kidney stones are very common. They affect 3-5% of the population in the United States. Many people are hospitalized for the treatment of kidney stones and some may die. Better understanding of what causes kidney stones is useful in both the treatment and prevention of kidney stones. However, exactl...
What is the current status of trial NCT00169806?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 1998-11. Estimated completion is 2025-12.
What conditions does trial NCT00169806 study?
This clinical trial studies the following conditions: Hyperparathyroidism, Renal Calculi, Cystinuria, Hypercalciuria, Nephrocalcinosis.
What interventions are being tested in trial NCT00169806?
The interventions under investigation include: videotape for mapping of renal anatomy and papillary biopsy (OTHER).
Who is sponsoring clinical trial NCT00169806?
This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00169806 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperparathyroidism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
STP.168 Clinical Study Protocol Parakeet
ACTIVE NOT RECRUITING · NA
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RECRUITING
-
Parathyroidectomy and Mobility Study
RECRUITING
-
Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
COMPLETED · Phase 3
-
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
COMPLETED · Early Phase 1
-
Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia